Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $104.35 USD
Change Today -0.10 / -0.10%
Volume 659.4K
INCY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 3:31 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - incyte corp (INCY)

Name (Connections)Board RelationshipsTitleKey Developments
Wendy Dixon Ph.D. 67 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 
Paul Clancy M.B.A. 24 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - incyte corp (INCY)

Name (Connections)Board RelationshipsTitle
Julian Baker 51 RelationshipsVice Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Finance Committee
Paul Brooke 30 RelationshipsDirector, Chairman of Finance Committee, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
INCY Compensation vs. Industry
738.5K
362.8K
Chief Executive Officer
63.8K
266.4K
Chief Financial Officer
Share price activity for INCYTE CORP (INCY)
52 Week Price Performance
INCY
Industry Average

Nominating Committee* - incyte corp (INCY)

Name (Connections)Board RelationshipsTitleKey Developments
Julian Baker 51 RelationshipsVice Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Finance CommitteeIncyte Corporation Announces Creation of Two New Units; Announces Executive Changes
06/19/15
Paul Brooke 30 RelationshipsDirector, Chairman of Finance Committee, Chairman of Compensation Committee and Member of Nominating & Corporate Governance CommitteeIncyte Corporation Announces Management Changes
05/4/15
Wendy Dixon Ph.D. 67 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeIncyte Corporation Appoints Steven H. Stein as Senior Vice President and Chief Medical Officer
03/2/15

Corporate Governance Committee* - incyte corp (INCY)

Name (Connections)Board RelationshipsTitle
Julian Baker 51 RelationshipsVice Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Finance Committee
Paul Brooke 30 RelationshipsDirector, Chairman of Finance Committee, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Wendy Dixon Ph.D. 67 Relationships--
INCY and Competitor
Insiders vs. External
Board
14%
86%
Incyte Corporation
29%
71%
Alkermes plc
20%
80%
Ariad Pharmaceuticals Inc.
6%
94%
BioMarin Pharmaceutical Inc.
13%
87%
Vertex Pharmaceuticals Incorporated
9%
91%
Jazz Pharmaceuticals Public Limited Company
Insiders
External Board Members

Finance Committee* - incyte corp (INCY)

Name(Connections)Board RelationshipsTitle
Julian Baker 51 RelationshipsVice Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Finance Committee
Paul Brooke 30 RelationshipsDirector, Chairman of Finance Committee, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Paul Friedman M.D. 75 RelationshipsDirector and Member of Finance Committee
Debt To Total Capitalization106.3x
It is important for the finance committee to know when to issue debt or equity.

Committee of Directors* - incyte corp (INCY)

Name (Board Relationships)/TitleBoard Affiliations
Herve Hoppenot 6 Relationships
Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $104.40 USD -0.055

INCY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $62.95 USD -1.82
ARIAD Pharmaceuticals Inc $7.92 USD -0.17
BioMarin Pharmaceutical Inc $136.51 USD -0.22
Jazz Pharmaceuticals PLC $177.59 USD +0.46
Vertex Pharmaceuticals Inc $130.85 USD +4.66
View Industry Companies
 

Industry Analysis

INCY

Industry Average

Valuation INCY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 30.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 29.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.